Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

un1Qure Genezen
Biotech

uniQure stock crashes as Huntington’s gene therapy data weaken

Mitigating circumstances and the ongoing strength of a secondary endpoint kept analysts optimistic about AMT-130’s path to approval.
Nick Paul Taylor Sep 29, 2026 9:28am
apoptosis cell death cancer cell death

ai3Bio buzzing with $48M for STING pathway targeting pipeline

Sep 29, 2026 9:00am
video
Biotech value creation at an inflection point

Biotech value creation at an inflection point

Brought to you by Lumanity
Novo Nordisk

Novo agrees $2.6B deal for Hengrui's preclinical GLP-1/GIP drug

Sep 29, 2026 3:50am
video
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
Summit

AstraZeneca scales Summit’s PD-1xVEGF combos with $2B investment

Sep 29, 2026 3:07am